NetApp Inc (NASDAQ:NTAP), which happens to be a top end Data Innovation Summit platinum sponsor, has through a statement revealed its plans to move ahead and showcase solutions that would see to it that all the customers are in a position to maximize the value of their data as well as accelerate big data analytics applications.
According to a number of top trusted sources, the conference is supposedly to be held in April 19–20, 2017 which is as a matter of fact set to take place at the Westin St. Francis Hotel in San Francisco.
At this particular moment, customers have been empowered in such a great way since they can now connect with subject matter experts as well as the top NetApp executives in a concerted effort targeting the push to have the technology demonstrations in booth 300.
A lot has been happening in the company and all of its has been in an effort to help the company forge forward in terms of generating higher revenues as well as facilitating major expansions. While speaking to news reporters, one of the company’s top executives expressed that the company was now more than ever committed to better serving its wide array of customers as well as in the spearheading of the continued growth of its business.
He added to say that there was actually great need to speed up innovation which would of course be given a major boost by some top end and flexible solutions. The company currently prides itself in having best and newest in terms of infrastructure that will as a matter of fact facilitate the scaling up of business operations.
The enhancement of fast access to information is a great thing. The company has moved ahead to make public that indeed there has been increased productivity, and that has been closely linked to employees being given immediate access to information.
NetApp Inc is happy about the fact that over the years it has done pretty well when it comes to offering top organizations worldwide with software, systems and services that make it easy for them to safely store important data.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:
The Next Big Thing In Biotech?https://journaltranscript.com
Get our top rated alerts on the biotech sector
A new field of medicine needs attentionhttps://journaltranscript.com
Here are the reasons to invest in CMXC
Traders Need To Know This Nowhttps://journaltranscript.com
WallStreet is loading up on this stock. Find out why